Stomach device Switch-Off may reveal insulin secrets

NCT ID NCT07635576

Recruiting now Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study looks at people with gastroparesis (slow stomach emptying) who have a gastric electrical stimulator (GES) implanted. Researchers will turn off the device for up to four hours to see how it changes insulin and other hormone levels. The goal is to understand the device's effect on the body, not to treat a condition. Participants must be at least 18, have had the device for three months, and not use insulin for diabetes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Gastric Electrical Stimulator (device)
What this could lead to: If successful, this could clarify how gastric stimulation affects insulin and blood sugar, potentially guiding future treatments for gastroparesis.
What could go wrong: This is a small, early observational study with only 32 participants, so results may not apply widely. It does not test a new treatment or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROPARESIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroparesis idiopathic gastroparesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTROPARESIS NONDIABETIC

Contacts and locations

Locations

Indiana University Hospital
RECRUITING

Indianapolis, Indiana, 46202, United States
Indiana University Hospital
RECRUITING

Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.